SurgiVance, Inc.
PrivateLast Round
Grant
Jul 24, 2025
Total Funding Raised
$4.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SurgiVance, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in July 2025.
SurgiVance, Inc. is a medical device company that develops AI-driven, direct-to-digital confocal pathology imaging technology for point-of-care cancer diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SurgiVance, Inc. Comparables
Compare SurgiVance, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MUSE Microscopy, Inc. | 87% | |
| Instapath Inc. | 85% | |
| Invenio Imaging | 84% |
For institutional investors. Book with your work email.
SurgiVance, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 24, 2025 | ||||
| Grant | Jul 24, 2025 | ||||
| Grant | Jan 10, 2022 | ||||
| Grant | Aug 1, 2019 |
For institutional investors. Book with your work email.
SurgiVance, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Portland Seed Fund | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 200% QoQ, from 2 to 6 employees.
- May 11, 2026
Monthly visitors grew 104% MoM.
For institutional investors. Book with your work email.
SurgiVance, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SurgiVance, Inc.'s valuation, stock price, and market status.
Is SurgiVance, Inc. a public or private company?
SurgiVance, Inc. is a private company.
What is the current stock price of SurgiVance, Inc.?
SurgiVance, Inc. is a private company, so its shares have no public market price. Caplight tracks SurgiVance, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SurgiVance, Inc. worth (valuation)?
Valuation information for SurgiVance, Inc. is not publicly available.
Can I buy SurgiVance, Inc. stock?
SurgiVance, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SurgiVance, Inc.'s last funding round?
SurgiVance, Inc.'s most recent funding round was Grant on July 24, 2025.
Who are the main investors in SurgiVance, Inc.?
Key investors in SurgiVance, Inc. include National Cancer Institute, Portland Seed Fund, National Science Foundation.
Will SurgiVance, Inc. IPO soon?
No public IPO plans have been announced for SurgiVance, Inc..
How can I track SurgiVance, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SurgiVance, Inc.'s shares on secondary markets.